Cambrex Expands Snapdragon Chemistry Facility In Massachusetts
Adds an additional 12,000 square feet to Snapdragon's API development and manufacturing facility.
Source: contractpharma.com
Stay updated with breaking news from Cleaning Validation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adds an additional 12,000 square feet to Snapdragon's API development and manufacturing facility.
Junshi Biosciences will grant a license to Dr. Reddy’s to develop and exclusively commercialize toripalimab in certain countries.
Transaction includes BPS manufacturing facilities and approximately 1,700 employees in Bloomington, IN and Halle, Germany.
Creates a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,000 pallet locations.
The new space will increase laboratory space dedicated to analytical R&D activities for small molecules by more than 130%.